Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

BioNeutra Global Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

BioNeutra Global şirketinin toplam hissedar öz sermayesi CA$-7.8M ve toplam borcu CA$7.5M olup, bu da borç-öz sermaye oranını -96.3% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CA$14.4M ve CA$22.2M dir.

Anahtar bilgiler

-96.3%

Borç/özkaynak oranı

CA$7.51m

Borç

Faiz karşılama oranı	n/a
Nakit	CA$355.24k
Eşitlik	-CA$7.80m
Toplam yükümlülükler	CA$22.16m
Toplam varlıklar	CA$14.36m

Son finansal sağlık güncellemeleri

Recent updates

Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Dec 30

A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Aug 24

We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed

Sep 15

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

Jul 12

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

Mar 29

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Dec 14

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BGA negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: BGA şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BGA negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: BGA 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: BGA şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: BGA un, serbest nakit akışı her yıl % 26.7 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

BioNeutra Global Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 1/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Recent updates

High number of new directors

Second quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.027 loss in 2Q 2023)

BioNeutra Global Corporation, Annual General Meeting, Sep 09, 2024

First quarter 2024 earnings released: CA$0.02 loss per share (vs CA$0.02 loss in 1Q 2023)

Less than half of directors are independent

Full year 2023 earnings released: CA$0.05 loss per share (vs CA$0.063 loss in FY 2022)

BioNeutra Global Corporation Appoints Stephen Jakeway as Chief Operating Officer

Less than half of directors are independent

Third quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.027 loss in 3Q 2022)

Less than half of directors are independent

BioNeutra Global Corporation Appoints Mr. Bill Smith to the Board of Directors

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

BioNeutra Global Corporation Announces Executive Changes

Less than half of directors are independent

Full year 2022 earnings released: CA$0.06 loss per share (vs CA$0.061 loss in FY 2021)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Calculating The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Less than half of directors are independent

Third quarter 2022 earnings released: CA$0.03 loss per share (vs CA$0.016 loss in 3Q 2021)

Less than half of directors are independent

Now 40% undervalued

A Look At The Fair Value Of BioNeutra Global Corporation (CVE:BGA)

Second quarter 2022 earnings released: CA$0.01 loss per share (vs CA$0.001 loss in 2Q 2021)

Less than half of directors are independent

BioNeutra Global Corporation Appoints Ross Montagano as Chief Operating Officer

Less than half of directors are independent

First quarter 2022 earnings released

BioNeutra Global Corporation, Annual General Meeting, Jul 08, 2022

Full year 2021 earnings released: CA$0.06 loss per share (vs CA$0.08 loss in FY 2020)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Less than half of directors are independent

Less than half of directors are independent

We Discuss Why BioNeutra Global Corporation's (CVE:BGA) CEO Compensation May Be Closely Reviewed

Is BioNeutra Global (CVE:BGA) Using Too Much Debt?

First quarter 2021 earnings released: CA$0.03 loss per share (vs CA$0.024 loss in 1Q 2020)

Chairman Peter Watson has left the company

Is BioNeutra Global (CVE:BGA) Weighed On By Its Debt Load?

New 90-day high: CA$0.30

Does BioNeutra Global (CVE:BGA) Have A Healthy Balance Sheet?

Third quarter 2020 earnings released: CA$0.001 loss per share

Bioneutra Global Corporation Announces Executive Appointments

Bioneutra Global Corporation Appoints Bill Smith as Senior Vice President

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin